Aurobindo Pharma Limited has informed the National Stock Exchange of India Limited (NSE) and BSE Limited about its participation in an investor/analyst meeting.
Company officials will participate in the J.P. Morgan India Investor Conference scheduled for September 22, 2026. The meeting will take place from 09:00 AM to 5:00 PM Indian Standard Time (IST) in Mumbai.
The meeting will include both one-on-one and group meeting formats. The company specifically noted that the schedule is subject to change due to exigencies on the part of either the investor or the company.
Importantly, the company has explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
The disclosure was made through a formal letter addressed to both stock exchanges' listing departments, signed by B. Adi Reddy, Company Secretary, on September 11, 2026, at 15:20:37 IST.